biotech · Hypoglycemia · Diabetes Mellitus, Type 1 · XERS
Xeris Biopharma Holdings
Xeris Biopharma Holdings trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
Chicago, USA HQ
2005 Founded
496 Employees
Public company Type
XERS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Chicago, USA
- Founded
- 2005
- Employees
- 496
- Programs
- 16
- Drugs
- 12
- Patents
- 24
Xeris Biopharma Holdings clinical trials
Registry index of 17 ClinicalTrials.gov studies linked to Xeris Biopharma Holdings programs — each row shows trial ID, program name, phase, status, and indication.
Xeris Biopharma Holdings trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Xeris Biopharma Holdings.
-
Novo Nordisk GlucaGen® — Phase 2
Clinical update -
levothyroxine sodium — Phase 2
Clinical update -
Glucagon RTU Injection With Insulin Pump Reduction — Phase 2
Clinical update -
Glucagon RTU — Phase 2
Clinical update -
Glucagon — Phase 2
Clinical update -
G-Pump™ (glucagon infusion) — Phase 2
Clinical update -
G-Pen Mini™ (glucagon injection) — Phase 2
Clinical update -
G-Pen Mini™ (glucagon injection) — Phase 2
Clinical update